Cargando…
Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depressive Disorder
Patients with major depressive disorder (MDD) have clinically relevant, significant decreases in bone mineral density (BMD). We sought to determine if predictive markers of bone inflammation—the osteoprotegerin (OPG)-RANK-RANKL system or osteopontin (OPN)—play a role in the bone abnormalities associ...
Autores principales: | Kadriu, Bashkim, Gold, Philip W, Luckenbaugh, David A, Lener, Marc S, Ballard, Elizabeth D, Niciu, Mark J, Henter, Ioline D, Park, Lawrence T, De Sousa, Rafael Teixeira, Yuan, Peixiong, Machado-Vieira, Rodrigo, Zarate, Carlos A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709243/ https://www.ncbi.nlm.nih.gov/pubmed/28555075 http://dx.doi.org/10.1038/mp.2017.109 |
Ejemplares similares
-
The Kynurenine Pathway and Bipolar Disorder: Intersection of the Monoaminergic and Glutamatergic Systems and Immune Response
por: Kadriu, Bashkim, et al.
Publicado: (2019) -
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018) -
Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2018) -
Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2019) -
Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
por: Mkrtchian, Anahit, et al.
Publicado: (2020)